vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and Ecovyst Inc. (ECVT). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $199.4M, roughly 1.5× Ecovyst Inc.). Cellebrite DI Ltd. produced more free cash flow last quarter ($60.8M vs $22.9M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 18.7%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Ecovyst Inc. is a global sustainable specialty materials provider that develops and manufactures high-performance catalysts and functional additives. Its offerings serve key segments including industrial manufacturing, consumer goods, and environmental protection, helping clients improve operational efficiency and lower carbon emissions across North America, Europe, and Asia-Pacific markets.

CLBT vs ECVT — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.5× larger
CLBT
$292.2M
$199.4M
ECVT
More free cash flow
CLBT
CLBT
$37.9M more FCF
CLBT
$60.8M
$22.9M
ECVT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
18.7%
ECVT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
ECVT
ECVT
Revenue
$292.2M
$199.4M
Net Profit
$-302.3M
Gross Margin
84.6%
23.4%
Operating Margin
14.1%
10.9%
Net Margin
-103.5%
Revenue YoY
34.0%
Net Profit YoY
EPS (diluted)
$-1.50
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
ECVT
ECVT
Q4 25
$199.4M
Q3 25
$292.2M
$204.9M
Q2 25
$220.8M
$176.1M
Q1 25
$89.6M
$143.1M
Q4 24
$148.9M
Q3 24
$232.1M
$153.9M
Q2 24
$185.3M
$154.0M
Q1 24
$71.2M
$141.6M
Net Profit
CLBT
CLBT
ECVT
ECVT
Q4 25
Q3 25
$-302.3M
$-79.3M
Q2 25
$36.9M
$6.0M
Q1 25
$-71.4M
$-3.6M
Q4 24
Q3 24
$14.3M
Q2 24
$-95.2M
$8.3M
Q1 24
$-40.6M
$1.2M
Gross Margin
CLBT
CLBT
ECVT
ECVT
Q4 25
23.4%
Q3 25
84.6%
25.4%
Q2 25
84.1%
22.8%
Q1 25
85.2%
13.3%
Q4 24
28.9%
Q3 24
83.5%
29.3%
Q2 24
84.1%
27.3%
Q1 24
82.6%
23.5%
Operating Margin
CLBT
CLBT
ECVT
ECVT
Q4 25
10.9%
Q3 25
14.1%
13.8%
Q2 25
12.1%
9.0%
Q1 25
10.3%
-0.7%
Q4 24
15.1%
Q3 24
7.9%
17.9%
Q2 24
11.7%
14.1%
Q1 24
0.2%
9.5%
Net Margin
CLBT
CLBT
ECVT
ECVT
Q4 25
Q3 25
-103.5%
-38.7%
Q2 25
16.7%
3.4%
Q1 25
-79.7%
-2.5%
Q4 24
Q3 24
9.3%
Q2 24
-51.4%
5.4%
Q1 24
-57.0%
0.9%
EPS (diluted)
CLBT
CLBT
ECVT
ECVT
Q4 25
$0.06
Q3 25
$-1.50
$-0.69
Q2 25
$0.15
$0.05
Q1 25
$-0.36
$-0.03
Q4 24
$-0.26
Q3 24
$-0.35
$0.12
Q2 24
$-0.48
$0.07
Q1 24
$-0.21
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
ECVT
ECVT
Cash + ST InvestmentsLiquidity on hand
$191.7M
$197.2M
Total DebtLower is stronger
$392.6M
Stockholders' EquityBook value
$336.0M
$603.4M
Total Assets
$690.6M
$1.3B
Debt / EquityLower = less leverage
0.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
ECVT
ECVT
Q4 25
$197.2M
Q3 25
$191.7M
$82.0M
Q2 25
$326.1M
$69.6M
Q1 25
$191.7M
$127.5M
Q4 24
$131.4M
Q3 24
$189.5M
$123.5M
Q2 24
$178.6M
$83.3M
Q1 24
$189.5M
$103.1M
Total Debt
CLBT
CLBT
ECVT
ECVT
Q4 25
$392.6M
Q3 25
$854.8M
Q2 25
$856.6M
Q1 25
$859.0M
Q4 24
$860.8M
Q3 24
$862.7M
Q2 24
$862.4M
Q1 24
$866.2M
Stockholders' Equity
CLBT
CLBT
ECVT
ECVT
Q4 25
$603.4M
Q3 25
$336.0M
$607.9M
Q2 25
$408.4M
$692.4M
Q1 25
$336.0M
$698.7M
Q4 24
$700.5M
Q3 24
$34.2M
$729.4M
Q2 24
$-40.2M
$717.3M
Q1 24
$34.2M
$711.4M
Total Assets
CLBT
CLBT
ECVT
ECVT
Q4 25
$1.3B
Q3 25
$690.6M
$1.7B
Q2 25
$787.4M
$1.8B
Q1 25
$690.6M
$1.8B
Q4 24
$1.8B
Q3 24
$532.9M
$1.8B
Q2 24
$556.6M
$1.8B
Q1 24
$532.9M
$1.8B
Debt / Equity
CLBT
CLBT
ECVT
ECVT
Q4 25
0.65×
Q3 25
1.41×
Q2 25
1.24×
Q1 25
1.23×
Q4 24
1.23×
Q3 24
1.18×
Q2 24
1.20×
Q1 24
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
ECVT
ECVT
Operating Cash FlowLast quarter
$66.2M
$41.8M
Free Cash FlowOCF − Capex
$60.8M
$22.9M
FCF MarginFCF / Revenue
20.8%
11.5%
Capex IntensityCapex / Revenue
1.8%
9.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$69.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
ECVT
ECVT
Q4 25
$41.8M
Q3 25
$66.2M
$55.3M
Q2 25
$53.5M
$33.0M
Q1 25
$10.0M
$10.3M
Q4 24
$43.5M
Q3 24
$58.2M
$59.9M
Q2 24
$24.6M
$10.0M
Q1 24
$12.5M
$36.5M
Free Cash Flow
CLBT
CLBT
ECVT
ECVT
Q4 25
$22.9M
Q3 25
$60.8M
$53.2M
Q2 25
$47.5M
$7.8M
Q1 25
$8.5M
$-14.0M
Q4 24
$30.9M
Q3 24
$55.3M
$53.6M
Q2 24
$21.0M
$-9.3M
Q1 24
$11.4M
$19.1M
FCF Margin
CLBT
CLBT
ECVT
ECVT
Q4 25
11.5%
Q3 25
20.8%
26.0%
Q2 25
21.5%
4.4%
Q1 25
9.5%
-9.8%
Q4 24
20.7%
Q3 24
23.8%
34.9%
Q2 24
11.3%
-6.1%
Q1 24
16.0%
13.5%
Capex Intensity
CLBT
CLBT
ECVT
ECVT
Q4 25
9.4%
Q3 25
1.8%
1.0%
Q2 25
2.7%
14.4%
Q1 25
1.7%
16.9%
Q4 24
8.5%
Q3 24
1.3%
4.1%
Q2 24
1.9%
12.5%
Q1 24
1.5%
12.3%
Cash Conversion
CLBT
CLBT
ECVT
ECVT
Q4 25
Q3 25
Q2 25
1.45×
5.52×
Q1 25
Q4 24
Q3 24
4.21×
Q2 24
1.20×
Q1 24
29.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

ECVT
ECVT

Industrial Mining Automotive$101.3M51%
Regeneration And Treatment Services$90.0M45%
Other$8.1M4%

Related Comparisons